Tenofovir Disoproxil Fumarate remains a cornerstone antiretroviral in Australia, used for both HIV combination therapy and chronic Hepatitis B. Tavin, the Indian generic of Viread, provides Sydney patients proven efficacy at significantly reduced cost.
For HIV, Tavin is combined with Emtricitabine and a third agent; for Hepatitis B, it works effectively alone, achieving viral suppression in most patients. Sydney specialists managing HIV-Hepatitis B co-infected patients value its dual antiviral activity.
FAQ: Why would my doctor choose TDF (Tavin) over newer TAF-based medicines?
TDF remains an excellent and well-studied option, particularly valued for its strong efficacy against Hepatitis B and its lower cost. While TAF-based alternatives have a slightly better kidney and bone safety profile, TDF is entirely appropriate for most patients, especially those with normal kidney function. Many Sydney physicians prescribe TDF as first-line therapy and only switch to TAF if kidney function monitoring shows early changes over time.
